guanabenz and Metabolic Syndrome

guanabenz has been researched along with Metabolic Syndrome in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Charpin-El Hamri, G; Christen, M; Folcher, M; Fussenegger, M; Ye, H; Zwicky, K	1
Ernsberger, P; Kossover, R; Previs, SF; Velliquette, RA	1

Other Studies

2 other study(ies) available for guanabenz and Metabolic Syndrome

Article	Year
Pharmaceutically controlled designer circuit for the treatment of the metabolic syndrome. Proceedings of the National Academy of Sciences of the United States of America, 2013, Jan-02, Volume: 110, Issue:1 Topics: Animals; Cyclic AMP Response Element-Binding Protein; Dose-Response Relationship, Drug; Drug Design; Gene Expression Regulation; Glucagon-Like Peptide 1; Guanabenz; Leptin; Metabolic Syndrome; Mice; Models, Molecular; Receptors, G-Protein-Coupled; Signal Transduction; Transgenes	2013
Lipid-lowering actions of imidazoline antihypertensive agents in metabolic syndrome X. Naunyn-Schmiedeberg's archives of pharmacology, 2006, Volume: 372, Issue:4 Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Antihypertensive Agents; Cell Membrane; Cholesterol; Clonidine; Disease Models, Animal; Female; Guanabenz; Hyperlipidemias; Imidazoles; Imidazoline Receptors; Liver; Male; Metabolic Syndrome; Oxazoles; Rats; Rats, Inbred SHR; Receptors, Drug; Rilmenidine; Triglycerides	2006

Article

Year

Pharmaceutically controlled designer circuit for the treatment of the metabolic syndrome.

Proceedings of the National Academy of Sciences of the United States of America, 2013, Jan-02, Volume: 110, Issue:1

Topics: Animals; Cyclic AMP Response Element-Binding Protein; Dose-Response Relationship, Drug; Drug Design; Gene Expression Regulation; Glucagon-Like Peptide 1; Guanabenz; Leptin; Metabolic Syndrome; Mice; Models, Molecular; Receptors, G-Protein-Coupled; Signal Transduction; Transgenes

2013

Lipid-lowering actions of imidazoline antihypertensive agents in metabolic syndrome X.

Naunyn-Schmiedeberg's archives of pharmacology, 2006, Volume: 372, Issue:4

Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Antihypertensive Agents; Cell Membrane; Cholesterol; Clonidine; Disease Models, Animal; Female; Guanabenz; Hyperlipidemias; Imidazoles; Imidazoline Receptors; Liver; Male; Metabolic Syndrome; Oxazoles; Rats; Rats, Inbred SHR; Receptors, Drug; Rilmenidine; Triglycerides

2006